Sofia, May 11, 2022 –Sqilline has transformed into a Clinical Research Organization (CRO). The company is set to further develop its innovative digital approach in clinical trials...
With a formal Grant Offer, on 13th of January 2022, Project „ Experimental development for creation of decision support application (Danny DSA) for breast and...
Sqilline took part in the Annual Oncology Conference MORE 2021. This year, the three main topics were: pancreatic cancer, national cancer plan, and digitization in...